TRHC:NSD-Tabula Rasa HealthCare Inc.

EQUITY | Application Software | NASDAQ Global Market

Last Closing Price

USD 68.43

Change

0.00 (0.00)%

Market Cap

USD 1.41B

Volume

0.28M

Average Target Price

USD 86.39 (26.24%)
Average Analyst Rating

Verdict

STA Verdict

Verdict

About

Tabula Rasa HealthCare Inc provides patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-01-21 )

Largest Industry Peers for Application Software

Symbol Name Price(Change) Market Cap
MSFT Microsoft Corporation

N/A

USD 826.81B
ADBE Adobe Inc.

N/A

USD 120.82B
INTU Intuit Inc.

N/A

USD 55.51B
CTSH Cognizant Technology Solutions..

N/A

USD 39.27B
WDAY Workday Inc.

N/A

USD 37.86B
ATVI Activision Blizzard Inc

N/A

USD 37.12B
ADSK Autodesk Inc.

N/A

USD 31.04B
EA Electronic Arts Inc.

N/A

USD 27.95B
TEAM Atlassian Corporation Plc

N/A

USD 21.59B
CA CA Inc.

N/A

USD 18.58B

ETFs Containing TRHC

DWMC AdvisorShares Dorsey Wrig.. 1.29 % 0.00 %

N/A

USD 1.52M
RZG Invesco S&P Smallcap 600 .. 1.22 % 0.35 %

N/A

USD 0.25B
IWC iShares Microcap 0.34 % 0.60 %

N/A

USD 0.92B

Market Performance

  Market Performance vs.
Industry/Classification (Application Software)
Market Performance vs. Exchange (NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.32% 44% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.32% 44% F 48% F
Trailing 12 Months  
Capital Gain 101.80% 94% A 97% A+
Dividend Return N/A N/A N/A N/A N/A
Total Return 101.80% 94% A 97% A+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 108.75% 98% A+ 98% A+
Dividend Return 108.75% 98% A+ 98% A+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 113.73% 7% F 5% F
Risk Adjusted Return 95.62% 81% B- 86% B
Market Capitalization 0.20B 57% F 75% C

Key Financial Ratios

  Ratio vs. Industry/Classification
(Application Software)
Ratio vs. Market
(NASDAQ Global Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio -56.55 87% B+ 95% A
Price/Book Ratio 17.37 13% F 5% F
Price / Cash Flow Ratio 20.61 9% F 3% F
Price/Free Cash Flow Ratio 195.51 6% F 2% F
Management Effectiveness  
Return on Equity -23.94% 28% F 28% F
Return on Invested Capital -33.27% 19% F 27% F
Return on Assets -12.09% 25% F 30% F
Debt to Equity Ratio 11.25% 75% C 76% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.